Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BREAST CANCER”

16,295 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 16,295 results

Testing effectiveness (Phase 2)WithdrawnNCT03326258
What this trial is testing

Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Advanced Malignant Solid NeoplasmEstrogen Receptor NegativeGPNMB Positive+15 more
National Cancer Institute (NCI)
Not applicableUnknownNCT02096185
What this trial is testing

Is Any Additional Information Gained Regarding Margins Using 3D Tomosynthesis Vs 2D Conventional Digital Imaging When Imaging Operative Breast Specimens?

Who this might be right for
Breast Cancer
Sandwell & West Birmingham Hospitals NHS Trust 50
Not applicableActive Not RecruitingNCT02276885
What this trial is testing

Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial

Who this might be right for
Breast Cancer
NYU Langone Health 284
Testing effectiveness (Phase 2)Study completedNCT00098397
What this trial is testing

FR901228 in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00247013
What this trial is testing

Automated Tele Counseling for Screening Mammography

Who this might be right for
Breast Cancer
Boston Medical Center 2,120
Not applicableUnknownNCT05830461
What this trial is testing

Online Psychological Care Program for Women Who Attend a Breast Clinic.

Who this might be right for
Breast Cancer
University of Guadalajara 50
Not applicableUnknownNCT01891123
What this trial is testing

Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy

Who this might be right for
Non-small Cell Lung CancerBreast CancerNasal Cancer
Sun Yat-sen University 300
Testing effectiveness (Phase 2)Looking for participantsNCT06954480
What this trial is testing

Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Queen Mary University of London 140
Testing effectiveness (Phase 2)Study completedNCT04758780
What this trial is testing

Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Institut Cancerologie de l'Ouest 12
Not applicableUnknownNCT02666079
What this trial is testing

The LightPath® Breast Cancer Study

Who this might be right for
Breast Cancer
Lightpoint Medical Limited 170
Not applicableStudy completedNCT02216162
What this trial is testing

PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention Program

Who this might be right for
Breast Cancer
Hospices Civils de Lyon 12
Testing effectiveness (Phase 2)Study completedNCT01269346
What this trial is testing

Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Eisai Inc. 52
Early research (Phase 1)Study completedNCT03854903
What this trial is testing

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Who this might be right for
Metastatic Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastHormone Receptor Positive Breast Cancer
Georgetown University 19
Testing effectiveness (Phase 2)Study completedNCT01262027
What this trial is testing

TKI258 for Metastatic Inflammatory Breast Cancer Patients

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 22
Not applicableStudy completedNCT00114270
What this trial is testing

Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density

Who this might be right for
Breast CancerOsteoporosis
University of Virginia
Testing effectiveness (Phase 2)Study completedNCT00089973
What this trial is testing

Study Of Ispinesib In Subjects With Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 50
Early research (Phase 1)Study completedNCT07235748
What this trial is testing

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Who this might be right for
Healthy Adult Participants
Institut de Recherches Internationales Servier (I.R.I.S.) 28
Testing effectiveness (Phase 2)UnknownNCT03879174
What this trial is testing

Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation

Who this might be right for
Breast Cancer Female
Mediclinic Middle East 25
Not applicableStudy completedNCT07086196
What this trial is testing

Real-World Outcomes of Ribociclib in First-Line Treatment for Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Metastatic HR+/HER2- Breast Cancer
Novartis Pharmaceuticals 350
Not applicableLooking for participantsNCT06322888
What this trial is testing

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

Who this might be right for
Breast CancerBreast Cancer Female
Dana-Farber Cancer Institute 46
Load More Results